DE69811120D1 - 6-o-alkyl erythronolid-b derivate - Google Patents

6-o-alkyl erythronolid-b derivate

Info

Publication number
DE69811120D1
DE69811120D1 DE69811120T DE69811120T DE69811120D1 DE 69811120 D1 DE69811120 D1 DE 69811120D1 DE 69811120 T DE69811120 T DE 69811120T DE 69811120 T DE69811120 T DE 69811120T DE 69811120 D1 DE69811120 D1 DE 69811120D1
Authority
DE
Germany
Prior art keywords
derivatives
alkyl
erythronolid
alkyl derivatives
erythronolide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811120T
Other languages
English (en)
Other versions
DE69811120T2 (de
Inventor
E Gracey
H Montgomery
A Riley
Jih-Hua Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69811120D1 publication Critical patent/DE69811120D1/de
Publication of DE69811120T2 publication Critical patent/DE69811120T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
DE69811120T 1997-12-01 1998-11-17 6-o-alkyl erythronolid-b derivate Expired - Fee Related DE69811120T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/980,919 US5919916A (en) 1997-12-01 1997-12-01 6-O-alkyl derivatives of erythronolide B
PCT/US1998/024497 WO1999028311A1 (en) 1997-12-01 1998-11-17 6-o-alkyl derivatives of erythronolide b

Publications (2)

Publication Number Publication Date
DE69811120D1 true DE69811120D1 (de) 2003-03-06
DE69811120T2 DE69811120T2 (de) 2003-10-09

Family

ID=25527957

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811120T Expired - Fee Related DE69811120T2 (de) 1997-12-01 1998-11-17 6-o-alkyl erythronolid-b derivate

Country Status (13)

Country Link
US (1) US5919916A (de)
EP (1) EP1040107B1 (de)
JP (1) JP2001524549A (de)
KR (1) KR20010032636A (de)
AT (1) ATE231851T1 (de)
AU (1) AU1526899A (de)
CA (1) CA2309977A1 (de)
DE (1) DE69811120T2 (de)
DK (1) DK1040107T3 (de)
ES (1) ES2191982T3 (de)
IL (1) IL135792A0 (de)
PT (1) PT1040107E (de)
WO (1) WO1999028311A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
SK13722002A3 (sk) * 2000-02-29 2003-08-05 Teva Pharmaceutical Industries Ltd. Spôsob prípravy klaritromycínu a klaritromycínového medziproduktu, v podstate prostého oxímu a farmaceutický prostriedok, ktorý ho obsahuje
EP1469008B1 (de) * 2000-03-15 2006-08-30 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 ａ의 제조방법
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US7825200B2 (en) * 2003-02-28 2010-11-02 The Regents Of The University Of California Controlled free radical grafting from polyolefins
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
DK2358379T3 (en) 2008-10-24 2016-03-07 Cempra Pharmaceuticals Inc BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
EP2613630A4 (de) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc Wasserstoffbindung zur formung von fluorketoliden zur behandlung von krankheiten
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharmaceutical Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH08149986A (ja) * 1994-09-28 1996-06-11 Taisho Pharmaceut Co Ltd １２−ヒドロキシ−６−ｏ−アルキルエリスロマイシン及びその類縁体の製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
ATE231851T1 (de) 2003-02-15
KR20010032636A (ko) 2001-04-25
PT1040107E (pt) 2003-06-30
AU1526899A (en) 1999-06-16
CA2309977A1 (en) 1999-06-10
DK1040107T3 (da) 2003-05-05
US5919916A (en) 1999-07-06
ES2191982T3 (es) 2003-09-16
DE69811120T2 (de) 2003-10-09
WO1999028311A1 (en) 1999-06-10
IL135792A0 (en) 2001-05-20
EP1040107B1 (de) 2003-01-29
JP2001524549A (ja) 2001-12-04
EP1040107A1 (de) 2000-10-04

Similar Documents

Publication Publication Date Title
DE69811120D1 (de) 6-o-alkyl erythronolid-b derivate
ATE256138T1 (de) 9-oximsilyl erythromycin a derivate
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
CY1106743T1 (el) Μεθοδος παρασκευης θειαμεθοξαμης
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO913745L (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
CY1107635T1 (el) Μεθοδος για την παρασκευη σιταλοπραμης
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
UA8017A1 (uk) Спосіб отримання похідних хінолінкарбонової кислоти
NO924028L (no) Forbedret fremgangsmaate for fremstilling av substituerte indolonderivater
NO901832L (no) Fremgangsmaate for fremstilling av polyketon.
NO903780L (no) Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO20000355D0 (no) Fremgangsmåte for fremstilling av cyklopropylacetylen
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
ITRM970270A0 (it) Soluzione colorante (gialla) per ceramica
ATE196292T1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
NO900969D0 (no) Fremgangsmaate for fremstilling av anilin-derivat.
NO952676D0 (no) Fremgangsmåte for fremstilling av pumpbare vandige leireblandinger
EE04305B1 (et) Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks
NO903196D0 (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
NO170578C (no) Fremgangsmaate for fremstilling n,n-dimetylaminometylarylforbindelser
UA25100A (uk) Припрацювальhа суміш

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee